These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8342231

  • 1. Differential effect of cryopreservation on natural killer cell and lymphokine-activated killer cell activities.
    Martí F, Miralles A, Peiró M, Amill B, de Dalmases C, Piñol G, Rueda F, García J.
    Transfusion; 1993 Aug; 33(8):651-5. PubMed ID: 8342231
    [Abstract] [Full Text] [Related]

  • 2. The influence of cryopreservation on activity and surface markers of lymphokine-activated killer cells.
    Letellier C, Rameliarison L, Fizet D, Ferrer AM, Vezon G.
    Vox Sang; 1991 Aug; 61(2):90-5. PubMed ID: 1763504
    [Abstract] [Full Text] [Related]

  • 3. Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission.
    Adler A, Chervenick PA, Whiteside TL, Lotzová E, Herberman RB.
    Blood; 1988 Mar; 71(3):709-16. PubMed ID: 3257887
    [Abstract] [Full Text] [Related]

  • 4. Induction of lymphokine-activated killer and natural killer cell activities from cryopreserved lymphocytes.
    Kawai H, Komiyama A, Katoh M, Yabuhara A, Miyagawa Y, Akabane T.
    Transfusion; 1988 Mar; 28(6):531-5. PubMed ID: 3264091
    [Abstract] [Full Text] [Related]

  • 5. Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes.
    Lamers HJ, Gratama JW, van Putten WL, Stoter G, Bolhuis RL.
    Cancer Res; 1991 May 01; 51(9):2324-8. PubMed ID: 2015597
    [Abstract] [Full Text] [Related]

  • 6. Lymphokine-activated killer cell activity after cryopreservation.
    Schmidt-Wolf IG, Aihara M, Negrin RS, Blume KG, Chao NJ.
    J Immunol Methods; 1989 Dec 20; 125(1-2):185-9. PubMed ID: 2607152
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo activity of murine lymphokine-activated killer cells after cryopreservation.
    Schmidt-Wolf IG, Aihara M, Negrin RS, Blume KG, Chao NJ.
    Transfusion; 1992 Jan 20; 32(1):42-5. PubMed ID: 1731434
    [Abstract] [Full Text] [Related]

  • 8. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA, Pekle K, Gazzola MV, Collins NH, Bourhis JH, Gillio A.
    J Immunol; 1989 Nov 15; 143(10):3241-9. PubMed ID: 2809200
    [Abstract] [Full Text] [Related]

  • 9. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J, van de Ven C, Cairo E, Hochberg J, Baxi L, Satwani P, Cairo MS.
    Exp Hematol; 2009 Oct 15; 37(10):1216-29. PubMed ID: 19638292
    [Abstract] [Full Text] [Related]

  • 10. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M, Hasegawa H, Nakayabu M, Fukai K, Suzuki S.
    J Clin Lab Immunol; 1993 Oct 15; 40(2):47-60. PubMed ID: 7932628
    [Abstract] [Full Text] [Related]

  • 11. Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation.
    Neubauer MA, Benyunes MC, Thompson JA, Bensinger WI, Lindgren CG, Buckner CD, Fefer A.
    Bone Marrow Transplant; 1994 Mar 15; 13(3):311-6. PubMed ID: 7911048
    [Abstract] [Full Text] [Related]

  • 12. Characterization of effector-target conjugates for cloned human natural killer and human lymphokine activated killer cells by flow cytometry.
    Callewaert DM, Radcliff G, Waite R, LeFevre J, Poulik MD.
    Cytometry; 1991 Mar 15; 12(7):666-76. PubMed ID: 1782834
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.
    Ayello J, van de Ven C, Fortino W, Wade-Harris C, Satwani P, Baxi L, Simpson LL, Sanger W, Pickering D, Kurtzberg J, Cairo MS.
    Biol Blood Marrow Transplant; 2006 Jun 15; 12(6):608-22. PubMed ID: 16737934
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lysis of human alveolar macrophages by lymphokine-activated killer cells.
    Maruyama M, Kawasaki A, Suzuki H, Yamashita N, Yano S.
    Chest; 1990 Jun 15; 97(6):1372-6. PubMed ID: 2347221
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lymphokine-activated killer cell function of lymphocytes from regional lymph nodes in patients with gastric carcinoma.
    Arinaga S, Karimine N, Nanbara S, Inoue H, Nakashima H, Ueo H, Akiyoshi T.
    J Surg Oncol; 1995 Jan 15; 58(1):44-9. PubMed ID: 7823572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.